ZG16 Monoklonaler Antikörper

ZG16 Monoklonal Antikörper für WB, IHC, IF-P, IF-Fro, Indirect ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

Hausschwein, human, Maus, Ratte

Anwendung

WB, IHC, IF-P, IF-Fro, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1A7B9

Kat-Nr. : 67389-1-PBS

Synonyme

1A7B9, FLJ43571, FLJ92276, hZG16, JCLN



Geprüfte Anwendungen

Produktinformation

67389-1-PBS bindet in WB, IHC, IF-P, IF-Fro, Indirect ELISA ZG16 und zeigt Reaktivität mit Hausschwein, human, Maus, Ratten

Getestete Reaktivität Hausschwein, human, Maus, Ratte
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen ZG16 fusion protein Ag11332
Vollständiger Name zymogen granule protein 16 homolog (rat)
Berechnetes Molekulargewicht 167 aa, 18 kDa
Beobachtetes Molekulargewicht 16 kDa
GenBank-ZugangsnummerBC029149
Gene symbol ZG16
Gene ID (NCBI) 653808
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Zymogen granule protein 16 (ZG16) has a Jacalin-like lectin domain, which is mainly expressed by mucus-secreting cells, including goblet cells in the intestine. It's reported that ZG16 expression was significantly decreased in colorectal cancer compared to normal tissue. ZG16 gene expression and copy number variations (CNV) were associated with multiple molecular and clinicopathological features of CRC including MSI, MLH1 silencing and so on. It's found that ZG16 is negatively correlated with lymphatic invasive and distant metastasis. Besides, overexpression of ZG16 blocks PD-L1 expression in colorectal cancer, and promotes NK cells survival and proliferation. Very importantly, ZG16 suppresses colorectal tumor growth via the immune system. (PMID: 33360840, 21893569)